U.K. Court Refuses To Dismiss Patent Suit Over Growth Hormone
A U.K. court has denied a motion by U.S. drug maker Insmed Inc. and its contract manufacturer, Avecia Group PLC, for summary judgment in Tercica's and Genentech's patent infringement lawsuit against...To view the full article, register now.
Already a subscriber? Click here to view full article